Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Increases By 52.4%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 3,200 shares, an increase of 52.4% from the August 15th total of 2,100 shares. Based on an average daily trading volume, of 105,900 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Stock Up 7.9 %

Shares of BCTXW stock traded up $0.01 during trading hours on Friday, reaching $0.19. 2,253 shares of the company’s stock were exchanged, compared to its average volume of 61,033. BriaCell Therapeutics has a fifty-two week low of $0.11 and a fifty-two week high of $2.60. The business has a fifty day moving average price of $0.21 and a 200-day moving average price of $0.64.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.